Event

Majd Mouded

MD
Biogen

Million Arefayene

PhD
Biogen

Bradley J. Maroni

MD
Biogen

Ivan O. Rosas

MD
Brigham & Womens;Brighams Women's Hospital

Diana C. Gallagher

MD
Biogen

Kevin F. Gibson

MD
Univ of Pittsburgh Med Ctr;Univiversity of Pittsburgh School of Medicine

Chris Stebbins

PhD
Biogen

Richard I. Enelow

MD
Dartmouth School of Medicine

Leo C. Ginns

MD
Massachusetts General Hospital

Antje Prasse

MD
Medical School;Medical School of Hannover

Mehrdad Arjomandi

MD
Univ of California San Francisco;University of California San Francisco;University of California,San Francisco

Dean Sheppard

MD
UCSF;University of California San Francisco;University of California, San Francisco

Naftali Kaminski

MD
Yale School of Medicine;Yale University;Yale University School of Medicine

Guolin Zhao

PhD
Biogen

Shelia Marie. Violette

PhD
Biogen

Hilary J. Goldberg

MPH, MD
Brigham and Womens Hosp;Brigham and Women's Hospital

Romy Christmann de Souza

MD PhD
Biogen

Daniel A. Culver

DO
Cleveland Clinic;Cleveland Clinic Foundation

Srihari Veeraraghavan

MD
Emory University School of Medicine

Guochen Song

DrPH
Biogen

Lisa Hood. Lancaster

M.D.
Vanderbilt Univ Medical Ctr;Vanderbilt University;Vanderbilt University Medical Center

Mark J. Hamblin

MD
The University of Kansas Medical Center;University of Kansas

Jeffrey A. Golden

MD
UCSF;University of California;University of California San Francisco;University of California, San Francisco

Ganesh Raghu

MD
Univ of Washington Medical Ctr

Adaani E. Frost

MD
Baylor College of Medicine;Houston Methodist Lung Center;Houston Methodist Lung Center, Weill-Cornell, Institute for Academic Medicine

Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose-Escalation Study of BG00011 (Formerly STX-100) in Patients with Idiopathic Pulmonary Fibrosis (IPF)